Legal Notice

All Osiris web site design, text, graphics, the selection and arrangement thereof, and software are the copyrighted works of Osiris Therapeutics, Inc., ©2007. All Rights Reserved.

THE SERVICE AND CONTENT FROM OR THROUGH THIS SITE ARE PROVIDED "AS IS", AND ALL WARRENTIES, EXPRESS OR IMPLIED, ARE DISCLAIMED (INCLUDING BUT NOT LIMITED TO THE DISCLAIMER OF ANY IMPLIED WARRENTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE). THE OWNER OF THIS SITE ASSUMES NO LIABILITY OR RESPONSIBILITY FOR ANY ERRORS OR OMISSIONS IN THE CONTENT CONTAINED ON THIS SITE

User agrees to indemnify, defend and hold Osiris Therapeutics, Inc., ("Osiris") and its affiliates, licensors, content and service providers, participating publishers and authors harmless from any liability, loss, claim and expense, including attorney's fees and expenses, related to a User's violation of this agreement or use of the Web site.

All responsibility or liability for any damages caused by any viruses contained within the electronic files or at the site is disclaimed.

This site contains links to other internet sites. Such links are not endorsements of any products or services in such sites, and no information in such site has been endorsed or approved by Osiris.

Forward Looking Statements

This web site contains forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, capital expenditures, compensation arrangements, financing needs, plans or intentions relating to acquisitions, business trends and other information that is not historical information. When used in this web site, the words estimates, expects, anticipates, projects, plans, intends, believes, forecasts and variations of such words or similar expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding the following: our product development efforts; our clinical trials and anticipated regulatory requirements; the success of our product candidates in development; status of the regulatory process for our biologic drug candidates; implementation of our corporate strategy; our financial performance; our product research and development activities and projected expenditures, including our anticipated timeline and clinical strategy for MSCs and biologic drug candidates; our cash needs; patents and proprietary rights; ability of our potential products to treat disease; our plans for sales and marketing; our plans regarding facilities; types of regulatory frameworks we expect will be applicable to our potential products; and results of our scientific research. All forward-looking statements, including, without limitations, management’s examination of historical operating trends, are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs and projections will result or be achieved. Our actual results could differ materially from those anticipated in forward-looking statements for many reasons, including the factors described in the section entitled "Risk Factors" and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K, as filed with the United States Securities and Exchange Commission on March 26, 2007. Accordingly, you should not unduly rely on these forward-looking statements. We undertake no obligation to publicly revise any forward-looking statement to reflect circumstances or events after the date of the statement or to reflect the occurrence of unanticipated events.